484 filings
Page 20 of 25
4
MYMD
MyMD Pharmaceuticals Inc
24 Oct 17
Akers Biosciences / GARY M RAUCH ownership change
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
19 Oct 17
Departure of Directors or Certain Officers
12:00am
424B5
MYMD
MyMD Pharmaceuticals Inc
16 Oct 17
Prospectus supplement for primary offering
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
10-Q
2017 Q2
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
14 Aug 17
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
11 Aug 17
Entry into a Material Definitive Agreement
12:00am
DEF 14A
MYMD
MyMD Pharmaceuticals Inc
Definitive proxy
24 Jul 17
12:00am
424B3
MYMD
MyMD Pharmaceuticals Inc
20 Jul 17
Prospectus supplement
12:00am
PRE 14A
MYMD
MyMD Pharmaceuticals Inc
13 Jul 17
Preliminary proxy
12:00am
EFFECT
MYMD
MyMD Pharmaceuticals Inc
30 Jun 17
Notice of effectiveness
12:00am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
29 Jun 17
Correspondence with SEC
12:00am
S-3/A
MYMD
MyMD Pharmaceuticals Inc
Shelf registration (amended)
26 Jun 17
12:00am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
5 Jun 17
Correspondence with SEC
12:00am
10-Q
2017 Q1
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
15 May 17
12:00am
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
4 May 17
Letter from SEC
12:00am
S-3
MYMD
MyMD Pharmaceuticals Inc
Shelf registration
19 Apr 17
12:00am
10-K/A
2016 FY
MYMD
MyMD Pharmaceuticals Inc
Annual report (amended)
18 Apr 17
12:00am
D
MYMD
MyMD Pharmaceuticals Inc
13 Apr 17
$2.03M in equity / options, sold $2.03M, 4 investors
12:00am
10-K
2016 FY
MYMD
MyMD Pharmaceuticals Inc
Annual report
11 Apr 17
12:00am
SC 13G
MYMD
MyMD Pharmaceuticals Inc
7 Apr 17
Akers Biosciences Inc
12:00am